Agilent Technologies ( (A) ) has released its Q1 earnings. Here is a breakdown of the information Agilent Technologies presented to its investors.
Agilent Technologies Inc., a leader in analytical and clinical laboratory technologies, provides a wide range of solutions including instruments, software, and services to help customers in scientific research and clinical diagnostics.
Agilent Technologies reported its financial results for the first quarter of fiscal year 2025, showing a revenue of $1.68 billion, which marks a 1.4% increase compared to the same period last year. The company also confirmed its core growth and earnings per share (EPS) expectations for the fiscal year.
Key financial metrics from the report include a GAAP net income of $318 million with an EPS of $1.11, which is a 6% decrease from the previous year. However, the non-GAAP net income was $377 million, with an EPS of $1.31, reflecting a 2% increase. The Life Sciences and Diagnostics Markets Group saw a 4% revenue increase, while the Agilent CrossLab Group experienced a 1% rise. The Applied Markets Group, however, reported a 4% decline in revenue.
Looking ahead, Agilent maintains its full-year revenue outlook between $6.68 billion and $6.76 billion, with non-GAAP EPS expected to range from $5.54 to $5.61. For the second quarter, the company anticipates revenue between $1.61 billion and $1.65 billion, with non-GAAP EPS projected between $1.25 and $1.28.
Agilent’s management remains optimistic about the company’s strategic initiatives and market-first strategy, which are expected to drive growth and improve decision-making processes, positioning the company for continued success in the fiscal year 2025.